Litigation
Azurity Pharmaceuticals, Inc. v. Helsinn Healthcare S.A.
trial instituted; pendingIPR2025-00949
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Filed
- 2025-05-01
Patents at issue (1)
Plaintiffs (1)
Defendants (1)
Summary
Azurity filed an inter partes review petition challenging U.S. 10,828,297 B2, owned by Helsinn, on obviousness grounds. The Board instituted trial on November 19, 2025, and the proceeding remains pending.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).